ETERNAL BEAUTY (06883) announced that on April 28, 2026, the company received a letter from the Stock Exchange. In the letter, the Exchange set forth the following guidance for the resumption of trading: (i) Conduct an appropriate independent forensic investigation into the service agreements signed with three service providers shortly after the company's listing, the letter of intent signed with one of these service providers, and/or any other similar agreements and/or arrangements; disclose the findings of the investigation; assess the impact on the company's business operations and financial condition; and implement appropriate remedial actions; (ii) Demonstrate that there are no reasonable regulatory concerns regarding the integrity, competence, and/or character of the group's management and/or any individuals with significant influence over the company's management and operations, so as not to pose risks to investors or damage market confidence; (iii) Appoint an independent internal control advisor to conduct an independent review of internal controls, and demonstrate that: the material weaknesses identified in relation to the trading suspension have been rectified, and all necessary remedial measures have been implemented; and the company's internal controls are adequate and effective for their purpose, enabling the company to comply with the Listing Rules in all material respects, including but not limited to financial reporting, disclosure and compliance concerning notifiable and connected transactions, and the disclosure of material information; (iv) Disclose all material information to the market to allow the company's shareholders and other investors to assess its status.